Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
24.31 USD  +0.28 (+1.17%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 16, 2014  /  Add to My Watchlist      
(IPXL) Community Analysis from
April 16, 2014
(Stock Blog Hub, 9/10/13)
Impax Laboratories, Inc. (IPXL) recently announced that it has launched its authorized generic version of AstraZeneca's (AZN) Zomig (zolmitriptan) tablets and orally...(read more)
(Stock Blog Hub, 5/15/13)
Impax Laboratories Inc.’s (IPXL) first quarter 2013 adjusted earnings of 37 cents per share were above the Zacks Consensus Estimate of 23 cents but below the year-ago earnings...(read more)
(Stock Wizard, 6/8/11)
Shares of Nokia Corp. (NYSE: NOK) slumped more than 3% on Wednesday after Samsung Electronics Co. declined to comment on market speculation that it could be preparing a bid for ailing...(read more)
Impax Laboratories Inc (IPXL) Company Overview

There is no analysis for IPXL yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here